GlassScriptPhysician profile
Raymond Weiand
NPI 1871537027
$3,568.98
in general payments reported to CMS, 2019-2025
15 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 87% of Neuromusculoskeletal Medicine, Sports Medicine providers received nationally (typical 2025 total: $125).
See the full distribution for Neuromusculoskeletal Medicine, Sports Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $34.34 · 2021: $429 · 2022: $543 · 2023: $475 · 2024: $146 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.19 |
| Travel and Lodging | $488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,477.61 | 2019-2025 | Gamma, Gravity Synchfix, Pangea |
| Arthrex, INC. | $616.40 | 2025 | |
| Smith+Nephew, INC. | $400.04 | 2019-2025 | Na, Q-Fix, Microraptor |
| Depuy Synthes Sales INC. | $353.48 | 2019-2025 | Speed, Intrafix |
| Reel Surgical, INC. | $304.53 | 2025 | |
| Medical Device Business Services, INC. | $124.99 | 2019 | |
| Zimmer Biomet Holdings, INC. | $96.60 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $52.63 | 2023 | Exparel, Iovera, Zilretta |
| Wright Medical Technology, INC. | $40.73 | 2019 | |
| Heron Therapeutics, INC. | $24.52 | 2023 | Zynrelef |
| Organogenesis INC. | $18.49 | 2023 | Puraply |
| US Implant Solutions, LLC | $16.46 | 2023 | |
| Embody, INC. | $16.30 | 2023 | |
| Orthofix Medical, INC. | $14.77 | 2023 | Physio-Stim |
| Pacira Therapeutics, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Weiand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.